Johnson & Johnson is a diversified global healthcare company that develops, manufactures and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.

U.S. stocks were higher on Thursday morning. Initial jobless claims were 212,000 for the latest week, unchanged from the previous-week's revised level. Ongoing unemployment was 1,812,000, virtually unchanged from the previous week. The Dow was up 0.5%, the S&P 500 rose 0.4% and the Nasdaq gained 0.3%. Crude oil is trading above $82 per barrel and gold rose $9 to $2397 per ounce.

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

STERIS PLC has an Investment Rating of HOLD; a target price of $240.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.